Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$5.76 USD
-0.01 (-0.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.75 -0.01 (-0.17%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Income Statements
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 872 | 1,543 | 1,545 | 1,249 | 854 |
Cost Of Goods | 42 | 46 | 39 | 25 | 24 |
Gross Profit | 830 | 1,497 | 1,506 | 1,224 | 830 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,160 | 853 | 834 | 725 | 508 |
Income After Depreciation & Amortization | -330 | 645 | 671 | 500 | 323 |
Non-Operating Income | -357 | 315 | 60 | -36 | 51 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -687 | 960 | 731 | 463 | 374 |
Income Taxes | -131 | 56 | 74 | 31 | -3 |
Minority Interest | 0 | 1 | 1 | 1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -556 | 904 | 657 | 432 | 376 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -556 | 903 | 656 | 431 | 375 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 302 | 1,007 | 1,022 | 789 | 488 |
Depreciation & Amortization (Cash Flow) | 632 | 363 | 351 | 289 | 165 |
Income After Depreciation & Amortization | -330 | 645 | 671 | 500 | 323 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 598.52 | 598.84 | 590.14 | 530.46 | 428.30 |
Diluted EPS Before Non-Recurring Items | -0.93 | 1.50 | 1.11 | 0.81 | 0.87 |
Diluted Net EPS (GAAP) | -0.93 | 1.50 | 1.11 | 0.81 | 0.87 |
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 266.56 | 271.32 | -122.38 | 306.58 | 337.40 |
Cost Of Goods | 7.66 | 4.82 | 3.30 | 6.48 | 24.68 |
Gross Profit | 258.90 | 266.50 | -125.68 | 300.09 | 312.72 |
SG&A, R&D, and Dept/Amort Expenses | 239.00 | 217.62 | 209.78 | 222.62 | 504.47 |
Income After SG&A, R&D, and Dept/Amort Expenses | 19.90 | 48.88 | -335.46 | 77.47 | -191.75 |
Non-Operating Income | -325.00 | -913.31 | -324.14 | 49.48 | 1.06 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -305.10 | -864.43 | -659.60 | 126.95 | -190.70 |
Income Taxes | 14.56 | 10.95 | 3.98 | 10.06 | -148.26 |
Minority Interest | 0.98 | 0.25 | 0.36 | 0.19 | -0.40 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -319.66 | -875.38 | -663.58 | 116.90 | -42.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -320.64 | -875.63 | -663.94 | 116.71 | -42.04 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 600.06 | 600.30 | 598.98 | 598.55 | 598.34 |
Diluted EPS Before Non-Recurring Items | -0.54 | -1.23 | -1.11 | 0.19 | -0.07 |
Diluted Net EPS (GAAP) | -0.54 | -1.46 | -1.10 | 0.19 | -0.07 |